Healthcare ❯Pharmaceuticals ❯Drug Development

Clinical Trials

Access to Healthcare Cholesterol Regulatory Agencies Executive Accountability Medical Research Patient Experiences Cost of Treatment Drug Sales Therapeutics Health Regulation

5 ARTICLES

3w ago

FDA Approves Yeztugo as First Twice-Yearly HIV Prevention Injection

Clinical trials showed nearly complete protection against HIV with a twice-yearly injection licensed for generic production in 120 low- and middle-income countries.

4 ARTICLES

last mo.

Mixed Phase 3 Outcomes Cloud Future of Regeneron and Sanofi’s COPD Candidate Itepekimab

5 ARTICLES

last mo.

GSK Acquires Experimental Liver Drug Efimosfermin for $1.2 Billion Upfront

8 ARTICLES

2mo ago

Eli Lilly Reports Record Q1 Revenue but Faces Profit Pressure and Competitive Challenges

6 ARTICLES

2mo ago

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

5 ARTICLES

3mo ago

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues

7 ARTICLES

3mo ago

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

4 ARTICLES

3mo ago

Ebola Pill Shows Promise in Monkey Trials, Raising Hopes for Human Treatment